BioPharma Credit (OTCMKTS:BOPCF) Shares Up 9.8% – Still a Buy?

BioPharma Credit PLC (OTCMKTS:BOPCF) was up 9.8% during mid-day trading on Tuesday . The stock traded as high as $0.86 and last traded at $0.86. Approximately 150,000 shares traded hands during mid-day trading, a decline of 30% from the average daily volume of 213,541 shares. The stock had previously closed at $0.78.

BioPharma Credit Stock Up 9.8 %

The company’s fifty day simple moving average is $0.81 and its 200 day simple moving average is $0.83.

BioPharma Credit Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 7th. Investors of record on Friday, April 4th will be paid a dividend of $0.0175 per share. This is a positive change from BioPharma Credit’s previous quarterly dividend of $0.01. The ex-dividend date of this dividend is Friday, April 4th. This represents a $0.07 annualized dividend and a yield of 8.15%.

BioPharma Credit Company Profile

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.